scispace - formally typeset
Y

Yueh-Te Lin

Researcher at Memorial Hospital of South Bend

Publications -  6
Citations -  153

Yueh-Te Lin is an academic researcher from Memorial Hospital of South Bend. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 1 publications receiving 53 citations.

Papers
More filters
Journal ArticleDOI

N6-Deoxyadenosine Methylation in Mammalian Mitochondrial DNA

TL;DR: It is reported that mammalian mitochondrial DNA (mtDNA) is enriched for 6mA, which is at least 1,300-fold higher than that in gDNA under normal growth conditions, corresponding to approximately four 6mA modifications on each mtDNA molecule.
Journal ArticleDOI

Quantifying Neutralizing Antibodies in Patients with COVID-19 by a Two-Variable Generalized Additive Model

TL;DR: A two-variable generalized additive model was used to analyze the results of the enzyme-linked immunosorbent assay and found the method to serve as a surrogate to quantify neutralizing antibody titers, which has potential for clinical use in assessing vaccine efficacy.
Journal ArticleDOI

Approaches for Detection of Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins and Their Application in Prediction of Higher Risk of Hepatocellular Carcinoma Development and Recurrence

TL;DR: The precise detection of pre-S gene deleting proteins holds great promise as regards identifying the patients at higher risk of HCC development and recurrence, thus aiding in more timely and better treatments to improve their survival.
Journal ArticleDOI

Factors influencing neutralizing antibody titers elicited by coronavirus disease 2019 vaccines

TL;DR: In this paper , the authors applied an international standard (IS) to calibrate neutralizing antibody titers (NTs) (international units/mL) in response to coronavirus disease 2019 (COVID-19) vaccination.
Journal ArticleDOI

USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1

TL;DR: The aim of the present study was to identify the mechanism underlying acquired resistance in TNBC through the exploration of the relationship between the expression of USP7 and of ABCB1, and found that ubiquitin specific protease 7 (USP7) is a potential therapeutic target for overcoming the chemoresistance of TNBC.